Wells Fargo’s Sophiris Bio, Inc. SPHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-523,933
| Closed | -$194K | – | 7355 |
|
|
2019
Q4 | $194K | Buy |
+523,933
| New | +$238K | ﹤0.01% | 4967 |
|
|
2019
Q1 | – | Sell |
-2,468
| Closed | -$2K | – | 6819 |
|
|
2018
Q4 | $2K | Sell |
2,468
-4,159
| -63% | -$8.18K | ﹤0.01% | 6241 |
|
|
2018
Q3 | $18K | Hold |
6,627
| – | – | ﹤0.01% | 5858 |
|
|
2018
Q2 | $19K | Buy |
6,627
+4,827
| +268% | +$14.3K | ﹤0.01% | 5833 |
|
|
2018
Q1 | $4K | Hold |
1,800
| – | – | ﹤0.01% | 6127 |
|
|
2017
Q4 | $4K | Hold |
1,800
| – | – | ﹤0.01% | 6119 |
|
|
2017
Q3 | $4K | Hold |
1,800
| – | – | ﹤0.01% | 6100 |
|
|
2017
Q2 | $4K | Hold |
1,800
| – | – | ﹤0.01% | 5990 |
|
|
2017
Q1 | $5K | Hold |
1,800
| – | – | ﹤0.01% | 6055 |
|
|
2016
Q4 | $5K | Hold |
1,800
| – | – | ﹤0.01% | 5973 |
|
|
2016
Q3 | $6K | Sell |
1,800
-2,000
| -53% | -$7.52K | ﹤0.01% | 5900 |
|
|
2016
Q2 | $8K | Buy |
3,800
+2,000
| +111% | +$2.76K | ﹤0.01% | 5739 |
|
|
2016
Q1 | $3K | Hold |
1,800
| – | – | ﹤0.01% | 6007 |
|
|
2015
Q4 | $3K | Hold |
1,800
| – | – | ﹤0.01% | 5998 |
|
|
2015
Q3 | $2K | Hold |
1,800
| – | – | ﹤0.01% | 6033 |
|
|
2015
Q2 | $1K | Hold |
1,800
| – | – | ﹤0.01% | 6307 |
|
|
2015
Q1 | $1K | Hold |
1,800
| – | – | ﹤0.01% | 6127 |
|
|
2014
Q4 | $1K | Hold |
1,800
| – | – | ﹤0.01% | 6167 |
|
|
2014
Q3 | $5K | Buy |
+1,800
| New | +$5.07K | ﹤0.01% | 5849 |
|
Other funds holding SPHS
Wells Fargo's SPHS Position: Q1 2020 in Review
Wells Fargo sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 523,933 shares — an estimated $194K sold.
Wells Fargo first reported a position in SPHS in Q3 2014 and held it in 19 quarters. The position peaked at $194K in Q4 2019. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.
- Wells Fargo reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
- Wells Fargo sold 523,933 Sophiris Bio, Inc. shares in Q1 2020, an estimated $194K.
- Wells Fargo first reported a position in Sophiris Bio, Inc. in Q3 2014 and held it in 19 quarters.
- Wells Fargo's Sophiris Bio, Inc. position peaked at $194K in Q4 2019.
- 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.
Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.